G protein - Coupled prostanoid receptors and the kidney

Annual Review of Physiology

Volumn 63, Issue , 2001, Pages 579-605

  Breyer, M D ^a   Breyer, R M ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Prostaglandin D2; Prostaglandin E2; Prostaglandin F2 ; Prostaglandin I2; Thromboxane A2

Indexed keywords

11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 7 (3 BENZENESULFONAMIDOBICYCLO[2.2.1]HEPT 2 YL) 5 HEPTENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; BERAPROST; BUTAPROST; CICAPROST; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FLUPROSTENOL; G PROTEIN COUPLED RECEPTOR; ILOPROST; LATANOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID RECEPTOR; RECEPTOR BLOCKING AGENT; RENIN; SC 51089; SC 53122; SULPROSTONE; THROMBOXANE A2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

DIURESIS; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; KIDNEY; RECEPTORS, PROSTAGLANDIN E;

EID: 0035047940     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.63.1.579     Document Type: Review

References (195)

1. Segmental synthesis and actions of prostaglandins along the nephron
2. Prostanoid biosynthesis and mechanisms of action
3. Human forearm and kidney conversion of arachidonic acid to prostaglandins
4. VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
5. Prostanoid receptors: Structures, properties, and functions
6. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy
7. Effect of flurbiprofen on renal function in patients with moderate renal insufficiency
8. Renal complications of nonsteroidal anti-inflammatory drugs
9. Aspirin lowers blood pressure in patients with renovascular hypertension
10. Relationship between renin release and blood pressure response to nonsteroidal anti-inflammatory drugs in hypertension
11. Prostanoids as mediators of prohypertensive and anti-hypertensive mechanisms
12. Renal syndromes associated with nonsteroidal antiinflammatory drugs
13. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat
14. Human genes for prostaglandin endoperoxide synthase-2, thromboxane synthase and prostacyclin synthase
15. Cloning and expression of cDNA for a human thromboxane A2 receptor
16. Mouse thromboxane A2 receptor: cDNA cloning, expression and northern blot analysis
17. Rat kidney thromaboxane A2 receptor: Molecular cloning signal transduction and intrarenal expression localization
18. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor
19. 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
20. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
21. Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo
22. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha
23. Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein
24. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder
25. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2
26. Clinical implications of prostaglandin and thromboxane A2 formation (1)
27. Increased renal formation of thromboxane A2 and prostaglandin F2 alpha in heart failure
28. Chronic thromboxane receptor blockade reduces renal injury in murine lupus nephritis
29. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: Effects of insulin therapy in the rat
30. Structure and expression of the murine thromboxane A2 receptor gene
31. Distribution of binding sites for thromboxane A2 in the mouse kidney
32. Characterization of glomerular thromboxane receptor sites in the rat
33. Thromoboxane binding and signal transduction in rat glomerular mesangial cells
34. Arthur C. Corcoran Memorial Lecture. The role of eicosanoids in angiotensin-dependent hypertension
35. Salt loading enhances rat renal TxA2/PGH2 receptor expression and TGF response to U-46,619
36. Modulating role for thromboxane in the tubuloglomerular feedback response in the rat
37. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic: Role of macula densa
38. Vasoconstrictor responses in thromboxane receptor knockout mice: Tubuloglomerular feedback and ureteral obstruction
39. Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells
40. Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy
41. Effect of dexamethasone on in vivo prostanoid production in the rabbit
42. Caffeine-induced hypercalciuria and renal prostaglandins: Effect of aspirin and n-3 polyunsaturated fatty acids
43. cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase
44. Prostaglandin E2-9-ketoreductase as a mediator of salt intake-related prostaglandin-renin interaction
45. Mechanism of increased renal prostaglandin E2 in uranyl nitrate-induced acute renal failure
46. The sub-type 2 angiotensin receptor regulates renal prostaglandin F2 alpha formation in conscious rats
47. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor
48. Cloning and expression of a cDNA for the human prostanoid FP receptor
49. Molecular cloning and expression of a cDNA of the bovine prostglandin F2a receptor
50. Cloning and expression of a cDNA for mouse prostaglandin F receptor
51. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
52. Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor
53. Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton
54. Differential regulation of prostaglandin F(2alpha) receptor isoforms by protein kinase C
55. Failure of parturition in mice lacking the prostaglandin F receptor
56. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and in-tracellular calcium mobilization
57. Expression of PGF(2alpha) receptor mRNA in normal, hyperplastic and neoplastic skin
58. Prostanoid-induced contraction of the rabbit isolated uterus is mediated by FP receptors
59. Expression of PGF(2alpha) receptor mRNA in normal, hyperplastic and neoplastic skin
60. Prostaglandin analogues in the treatment of glaucoma
61. Characterization of prostanoid receptors in podocytes
62. PGF2alpha-induced signaling events in glomerular mesangial cells
63. High potassium intake selectively increases urinary PGF2 alpha excretion in the rat
64. Characterization of the mouse prostaglandin F receptor gene: A transgenic mouse study of a regulatory region that controls its expression in the stomach and kidney but not in the ovary
65. Mammalian distal tubule: Physiology, pathophysiology, and molecular anatomy
66. Site and mechanism of action of trichlormethiazide in rabbit distal nephron segments perfused in vitro
67. Toward a comprehensive molecular model of active calcium reabsorption
68. Evidence that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct
69. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype
70. In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor
71. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
72. Cloning, tissue distribution, and intra-renal localization of prostaglandin E synthase in rabbit
73. Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex
74. Prostaglandin E2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat
75. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular volume depletion: Importance of intrarenal vasopressin-prostaglandin inter-action for protecting kidneys from constrictor action of vasopressin
76. Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa
77. Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells
78. Prostaglandin E2-induced hypertension in conscious dogs
79. Prostaglandins in renin release during sodium deprivation
80. Effect of indomethacin on blood pressure in rats with renovascular hypertension: Dependence on plasma renin activity
81. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists
82. Characterization of murine vasopressor and vasodepressor prostaglandin E2 receptors
83. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor sub-types
84. A new prostaglandin E receptor mediates calcium influx and acrosome reaction in human spermatozoa
85. Molecular evolution of receptors for eicosanoids
86. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney
87. Detection and quantitation of EP3 prostaglandin E2 receptor mRNA along mouse nephron segments by RT-PCR
88. Cloning and expression of the rabbit prostaglandin EP4 receptor
89. Differential localization of prostaglandin E receptor subtypes in human kidney
90. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor
91. Molecular characterization of the mouse prostanoid EP1 receptor gene
92. 8-chlorodibenz[B,F] [1,4]oxazepine-10(11H)-carboxylic acid, 2-[3-2-(furanylmethyl) thio]-1-oxopropyl] hydrazide(SC51322): A potent PGE2 antagonist and analgesic
93. N-substituted dibenzoxazepines as analgesic PGE2 antagonists
94. EP1 receptor antagonist blocks the diarrheagenic, but not cytoprotective, actions of a synthetic prostaglandin
95. Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype
96. Human prostanoid receptors: Cloning and characterzation
97. Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor
98. The mouse genes for the EP1 prostanoid receptor and the PKN protein kinase overlap
99. Prostaglandin E2 inhibits sodium transport in the rabbit CCD by raising intracellular calcium
100. Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions
101. Mice lacking the prostaglandin E2 EP1 receptor sub-type have hypotension, hyperreninemia and altered responses to angiotensin II
102. Identification of prostaglandin E receptor EP2 cloned from mastocytoma cells as EP4 subtype
103. Cloning and functional expression of the rabbit prostaglandin EP2 receptor
104. The mouse prostaglandin E receptor EP2 sub-type: Cloning, expression, and northern blot analysis
105. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype
106. Molecular cloning and expression of the rat prostaglandin E2 receptor of the EP2 subtype
107. Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype
108. A novel inhibitory prostanoid receptor in piglet saphenous vein
109. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor sub-type EP(2)
110. Prostaglandin E2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation
111. Hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
112. EP(2) receptor mediates bronchodilation by PGE(2) in mice
113. Molecular cloning and expression of human EP3 receptors: Evidence for three variants with different termini
114. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor
115. Splice variants of the human EP3 receptor for prostaglandin E2
116. Cloning and expression of the EP3-subtype of human receptors for prostaglandin E2
117. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines Gprotein specificity
118. Third isoform of the prostaglandin-E-receptor EP3 sub-type with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase
119. Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals
120. SC-46275: A potent and highly selective agonist at the EP3 receptor
121. Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: Requirement for two different tyrosine kinases
122. EP3 receptor activation of cAMP response element mediated gene transcription
123. Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity
124. Molecular cloning and intrarenal localization of rat prostaglandin E2 receptor EP3 subtype
125. Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3′5′monophosphate, and theophylline
126. A prostglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells
127. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle
128. - absorption by prostaglandin E2 and G-proteins in rat medullary thick ascending limb
129. Interactions among prostaglandin E2, antidiuretic hormone and cyclic adenosine monophosphate in modulating Cl-absorption in single mouse medullary thick ascending limbs of Henle
130. Inhibitory guanosine triphosphate-binding protein-mediated regulation of vasorpessin action in isolated single medullary tubules of mouse kidney
131. Regulation of cAMP metabolism by PGE2 in cortical and medullary thick ascending limb of Henle's loop
132. - absorption in rat MTAL by activation of protein kinase C
133. Evidence for an in vivo antagonism between vasopressin and prostaglandins in the mammalian kidney
134. Effect of prostaglandin E on renal hemodynamics, sodium, and water excretion
135. Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins
136. PGE2 inhibits AVP induced water flow in cortical collecting ducts by protein kinase C activation
137. Functional and molecular aspects of renal prostaglandin receptors
138. Luminal prostanglandin E receptors regulate salt and water transport in rabbit cortical collecting duct
139. Urinary concentrating function in mice lacking the EP3 receptors for prostaglandin E2
140. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
141. Identification of specific EP receptors responsible for the hemodynamic effects of PGE2
142. Cloning and expression of the EP2 sub-type of human receptors for prostaglandin E2
143. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype
144. Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype
145. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice
146. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
147. EP4 but not EP3 receptors mediate vasodilatory actions of PGE2
148. Prostaglandin E2-induced aldosterone release is mediated by an EP2 receptor
149. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat
150. Juxtaglomerular cell complex in the regulation of renal salt excretion
151. Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles
152. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
153. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells
154. Comparison of effects of prostaglandins E2 and I2 on rat renal vascular resistance
155. Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: Interaction with neuronal NOS
156. Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature
157. Reversal of indomethacin-induced inhibition of tubuloglomerular feedback by prostaglandin infusion
158. Inter-relationship between prostaglandins and renin release
159. Role of prostanoids in renin-dependent and renin-independent hypertension
160. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
161. Regulation of arterial pressure: Role of pressure natriuresis and diuresis
162. Blood pressure control - Special role of the kidneys and body fluids
163. Prostaglandins in the sodium excretory response to altered renal arterial pressure in dogs
164. Influence of prostaglandins on papillary blood flow and pressure - Natriuretic response
165. Vasoconstriction of outer medullary vasa recta by angiotensin II is modulated by prostaglandin E2
166. The regional distribution and cellular localization of mRNA encoding rat prostacyclin synthase
167. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
168. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
169. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
170. cDNA cloning of a mouse prostacyclin receptor: Multiple signaling pathways and expression in thymic medulla
171. Cloning and expression of a cDNA for the human prostanoid IP receptor
172. Prostanoids and their receptors
173. In situ hybridization studies on prostacyclin receptor mRNA expression in various mouse organs
174. Renal action of prostacyclin
175. Stimulation of renin release by PGE2 and PGI2 infusion in the dog: Enhancing effect of ureteral occlusion or administration of ethacrynic acid
176. Blood pressure, renal function, salt handling and renin release in prostacyclin receptor knockout mice
177. Prostaglandins and renin release. I. Simulation of renin release from rabbit renal cortical slices by PGI2
178. Prostanoid signaling, localization, and expression of IP receptors in rat thick ascending limb cells
179. Localization of the prostacyclin receptor in human kidney
180. Effects of prostacyclin on the cAMP system in cultured rat inner medullary collecting duct cells
181. Prostaglandin D synthase: Structure and function
182. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene
183. Molecular cloning and characterization of the human prostanoid DP receptor
184. Classification of platelet and vascular prostaglandin D2 (DP) receptors: Estimation of affinities and relative efficacies for a series of novel bicyclic ligands
185. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist
186. Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl-secretion in dog tracheal epithelium
187. Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain
188. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE
189. Prostaglandin D2 and sleep regulation
190. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice
191. Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats
192. Prostaglandin D(2) as a mediator of allergic asthma
193. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor
194. Dose-dependent effects of prostaglandin D2 on hemodynamics renal function, and blood gas analyses